Researchers should consult primary literature sources for full experimental protocols and outcomes
Hohenfellner K, Rauch F, Ariceta G, Awan A, Bacchetta J, Bergmann C, Bechtold S, Cassidy N, Deschenes G, Elenberg E, Gahl WA, Greil O, Harms E, Herzig N, Hoppe B, Koeppl C, Lewis MA, Levtchenko E, Nesterova G, Santos F, Schlingmann KP, Servais A, Soliman NA, Steidle G, Sweeney C, Treikauskas U, Topaloglu R, Tsygin A, Veys K, R VV, Zustin J, Haffner D (2019) Management of bone disease in cystinosis: statement from an international conference
Rebouche, 2004)
Debatri Datta April 10, 2024 Written By Dr
& Rosenberg, N
Regulatory Status GHK-Cu is not an FDA-approved drug